Clinical Trials Directory

Trials / Unknown

UnknownNCT01493466

Serum Proteomics Analysis for Sepsis

Serum Proteomics Analysis for Dynamic Changes of Differential Proteins in Sepsis Patient With iTRAQ Labeling and LC-MS/MS

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Serum proteomics is a very useful tool to identify various disease. The purpose of the present study was to find differential proteins among patient with normal, SIRS, sepsis, severe sepsis, death and to screen potential biomarkers for their dynamic changes. Serum proteins were identified by iTRAQ labeling and LC-MS/MS. The bioinformatics analysis was performed with the Mascot software and the International Protein Index (IPI) and the Gene Ontology (GO) Database and KEGG pathway Database. The differentially expressed proteins were verified by Western blot by another sample collected from clinical.

Conditions

Timeline

Start date
2010-05-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2011-12-16
Last updated
2011-12-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01493466. Inclusion in this directory is not an endorsement.

Serum Proteomics Analysis for Sepsis (NCT01493466) · Clinical Trials Directory